Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 5

Treatment Decision-Making in Chronic GVHD

Panelists discuss available treatment options for patients with chronic graft-vs-host disease (cGVHD) after steroid use, including factors that influence therapy selection, such as mechanism of action (MOA) and the mode of drug administration (oral vs intravenous [IV]).

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Understanding Graft-VS-Host Disease (GVHD) Basics
    EP. 2: Early Diagnosis and Intervention in GVHD Part 1
    EP. 3: Early Diagnosis and Intervention in GVHD Part 2
    EP. 4: Managing Skin Manifestations and Organ Involvement in GVHD
    Now Viewing
    EP. 5: Treatment Decision-Making in Chronic GVHD
    EP. 6: NCCN Guidelines and Clinical Updates in Chronic GVHD
    EP. 7: FDA-Approved Therapies for Chronic GVHD
    EP. 8: Challenges, Limitations, and Treatment Sequencing in Chronic GVHD
    EP. 9: Future Perspectives and Key Takeaways

    Video content above is prompted by the following:

    • What are the available treatment options for patients with chronic cGVvHD after steroid use?
    • How do you decide which therapy is best among the available treatment options?
    • How does MOA factor into your decision?
    • How will the administration of drugs (PO oral vs IV) factor into your treatment approach?
    x